BDBM208945 US9266880, 3
SMILES: Fc1ccc(cc1)-n1ncc2c(ccnc12)-c1cncc2ncccc12
InChI Key: InChIKey=UKRRLQNQNKOILD-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytochrome P450 17A1 (Homo sapiens (Human)) | BDBM208945 (US9266880, 3) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 41 | n/a | n/a | n/a | n/a | 7.2 | 4 |
Bristol-Myers Squibb Company US Patent | Assay Description The assays were performed in U-bottom 384-well optiplates. The final assay volume was 15 ul prepared from 7.5 ul additions of microsomes (prepared as... | US Patent US9266880 (2016) BindingDB Entry DOI: 10.7270/Q24T6H69 | |||||||||||
More data for this Ligand-Target Pair |